ParkwayLife REIT (SGX: C2PU) is one of Asia’s largest listed healthcare real estate investment trusts — and one of the most defensive income assets on the Singapore Exchange. With a 75-property portfolio spanning hospitals in Singapore and nursing homes across Japan and France, PLife REIT has delivered uninterrupted DPU growth for over a decade.
In 1Q 2026, PLife REIT posted a standout 15.1% DPU growth year-on-year, driven by the activation of a new rent review formula for its Singapore hospital master-lease. This guide covers everything Singapore investors need to know: share price, DPU history, yield, portfolio breakdown, risks, and 2026 outlook.
📋 Table of Contents
Table of Contents — Click to Expand
- What Is ParkwayLife REIT?
- Share Price & Key Stats (2026)
- DPU History & Dividend Growth
- Portfolio Breakdown: Singapore, Japan & France
- Financial Metrics & Gearing
- Singapore Hospital Master-Lease: The 2026 Catalyst
- 2026 Outlook & Growth Drivers
- Key Risks to Watch
- How to Buy PLife REIT in Singapore
- Frequently Asked Questions
What Is ParkwayLife REIT?
ParkwayLife Real Estate Investment Trust (SGX: C2PU) was listed on the Singapore Exchange in August 2007. It is structured as a pure-play healthcare REIT, meaning its entire portfolio consists of hospitals, nursing homes, and medical care facilities — making it uniquely defensive compared to office or retail REITs.
The REIT is sponsored by IHH Healthcare Berhad, one of Asia’s largest private hospital operators, which provides strong institutional backing and a ready pipeline of healthcare assets.
Key highlights at a glance:
- Total portfolio: 75 properties across 3 countries
- Total portfolio value: approximately S$2.46 billion
- Market cap: ~S$2.0 billion (as of May 2026)
- SGX Ticker: C2PU | Sector: Healthcare REIT
- Distribution frequency: Semi-annual (every 6 months)
- FY2025 DPU: 15.29 Singapore cents
PLife REIT is classified as a defensive REIT because healthcare demand is non-cyclical — hospitals and nursing homes are needed regardless of economic conditions. This makes it particularly attractive for retirement-focused investors seeking income stability.
If you are building a passive income portfolio, you may also want to read our guide on Best S-REITs in Singapore 2026 for a broader comparison of the top yield options.
ParkwayLife REIT DPU History & Dividend Growth
One of PLife REIT’s most compelling features is its unbroken record of DPU growth. Since listing in 2007, it has consistently grown its distribution per unit — a track record matched by very few REITs anywhere in Asia. This makes it a popular choice for investors who prioritise income reliability over high absolute yield.
| Financial Year | DPU (Singapore Cents) | YoY Change |
|---|---|---|
| FY2019 | 13.35¢ | +2.9% |
| FY2020 | 13.53¢ | +1.3% |
| FY2021 | 13.94¢ | +3.0% |
| FY2022 | 14.16¢ | +1.6% |
| FY2023 | 14.56¢ | +2.8% |
| FY2024 | 14.92¢ | +2.5% |
| FY2025 | 15.29¢ | +2.5% |
| 1Q 2026 (annualised) | ~17.68¢* | +15.1% YoY |
*1Q 2026 DPU of 4.42¢ × 4 quarters, indicative only. PLife REIT distributes semi-annually.
The 1Q 2026 result is particularly significant. The REIT posted DPU of 4.42 cents for the first quarter ended 31 March 2026, representing a 15.1% year-on-year jump. This was driven by the cessation of a three-year rent rebate for its Singapore hospitals and the activation of a new CPI-linked rent review formula — more on this below.
For context on how PLife REIT’s yield compares to other S-REITs, see our Best S-REITs Singapore 2026 guide. You can also compare its yield against the Singapore 10-year bond using our S-REIT Yield vs SGS Bond Spread Calculator.
Portfolio Breakdown: Singapore, Japan & France
PLife REIT’s 75-property portfolio is geographically diversified across three countries, though Singapore remains the dominant income contributor. Here is a breakdown of the portfolio as of early 2026:
Singapore: 3 Private Hospitals
The Singapore portfolio comprises three flagship private hospitals operated by IHH Healthcare’s Parkway Pantai subsidiary:
- Mount Elizabeth Hospital (Orchard Road) — a premier tertiary hospital
- Gleneagles Hospital (Buona Vista) — a leading specialist hospital
- Parkway East Hospital (Marine Parade) — a community hospital
Singapore accounts for 67.1% of gross revenue and 68.4% of net property income. The hospitals are held under a master-lease structure, providing guaranteed minimum rent with annual upward revisions. The 2021 lease renewal introduced a CPI-linked escalation mechanism, which kicked in fully in 2026, driving the significant DPU jump.
Japan: 60 Nursing Homes
Japan is PLife REIT’s largest portfolio by property count with 60 nursing homes spread across the country. Japan has an ageing population, making nursing home demand structurally strong. The REIT acquired its most recent Japan nursing home in August 2024.
Japan contributed approximately 28–30% of gross revenue. One tenant default in Japan created temporary disruption, but security deposits largely offset outstanding rental. The REIT is pursuing re-leasing and asset rejuvenation strategies for affected properties.
France: 11 Nursing Homes
In December 2024, PLife REIT completed its first European acquisition — 11 freehold nursing homes in France for €111.2 million (approximately S$157.3 million). These are operated by DomusVi Group under a 12-year indexed lease, providing long-term income visibility. France now contributes approximately 3–5% of gross revenue and adds further geographic diversification.
Portfolio Revenue Contribution (Approximate, 2025)
| Geography | Properties | % of Gross Revenue | Asset Type |
|---|---|---|---|
| Singapore | 3 | ~67% | Private hospitals |
| Japan | 60 | ~28–30% | Nursing homes |
| France | 11 | ~3–5% | Nursing homes (freehold) |
| Total | 74–75 | 100% | Healthcare |
Financial Metrics & Gearing
PLife REIT maintains a conservative financial profile that is well within Singapore’s regulatory limits for REITs:
| Financial Metric | Value | Comment |
|---|---|---|
| Gearing Ratio | 34.2% | Well below MAS 50% limit |
| Interest Cover Ratio (ICR) | 8.4x | Very strong; MAS minimum is 1.5x |
| All-in Debt Cost | 1.66% p.a. | Low due to JPY-denominated loans |
| Weighted Average Debt Maturity | 3.2 years | No major refinancing until Oct 2026 |
| Amount Available for Distribution (1Q26) | S$28.8 million | +15.1% YoY |
| Gross Revenue (1Q26) | S$38.2 million | -2.1% YoY (JPY weakness) |
The low all-in debt cost of 1.66% is a structural advantage — PLife REIT borrows heavily in Japanese Yen (JPY) to fund its Japan portfolio, and JPY interest rates remain low. This creates a natural hedge but also exposes the REIT to JPY/SGD currency risk.
Gross revenue declined 2.1% in 1Q 2026 largely due to JPY weakness against the SGD, even as the amount available for distribution grew strongly. This dynamic — where reported revenue can be impacted by currency while distributable income grows — is important to understand as a PLife REIT investor.
To model the impact of gearing on REIT returns, try our S-REIT Gearing Ratio & ICR Calculator.
Singapore Hospital Master-Lease: The 2026 Catalyst
The single biggest story for PLife REIT investors in 2026 is the activation of the new Singapore hospital rent review formula. Understanding this is essential to understanding why DPU jumped 15.1% in 1Q 2026.
Here is the timeline:
- 2021: PLife REIT renewed its Singapore hospital master-lease with IHH Healthcare for 20 years, effective from 2022. The renewal came with a ~40% rent increment versus the previous lease, a 27% rise in NAV, and a new CPI-linked escalation mechanism.
- 2022–2024: The REIT provided a three-year rent rebate to its Singapore hospital tenant (IHH Healthcare) as part of the transition terms.
- 2025–2026: The rent rebate period ended. Minimum rent for the Singapore hospitals jumped to S$99.1 million in FY2026, up 24.3% from FY2025.
This rent escalation is guaranteed under the master-lease contract and will continue to be reviewed periodically based on CPI. For investors, this means Singapore hospital income is now substantially higher and growing — a structural tailwind for DPU over the coming years.
ParkwayLife REIT 2026 Outlook & Growth Drivers
The outlook for PLife REIT in 2026 is broadly positive, driven by several structural tailwinds:
1. Singapore Hospital Rent Escalation
As described above, minimum rent from Singapore hospitals rose 24.3% in FY2026. This is a contractual step-up, not market-dependent — meaning it will flow through to DPU regardless of economic conditions.
2. France Nursing Homes — New Income Stream
The 11 French nursing homes acquired in December 2024 will contribute a full year of income in FY2025 and beyond. Operated under a 12-year indexed lease by DomusVi Group, these assets provide long-term income visibility and geographic diversification.
3. Japan Portfolio Stabilisation
While one Japan tenant default created headwinds, security deposits largely offset the impact. The REIT is actively re-leasing and repositioning affected properties. Japan’s structurally ageing demographic remains a long-term tailwind for nursing home demand.
4. Acquisition Headroom
With gearing at 34.2% and the MAS limit at 50%, PLife REIT has significant debt capacity to fund further acquisitions — estimated at over S$500 million without breaching regulatory limits. The REIT has stated that nursing homes in Japan and France remain key acquisition targets.
5. ESG & Institutional Demand
Healthcare REITs are increasingly favoured by ESG-focused institutional investors. PLife REIT’s pure healthcare focus, strong governance, and long-term tenant relationships position it well for continued institutional demand.
For investors building a CPF-supplemented dividend portfolio, you may want to read our CPF Investment Strategy guide to understand how S-REITs like PLife REIT can fit into a CPF-OA investment approach.
Key Risks to Watch
No investment is without risk. PLife REIT investors should be aware of the following:
1. JPY Currency Risk
With 60 nursing homes in Japan, PLife REIT has significant JPY exposure. A weakening JPY reduces the SGD value of Japan income. In 1Q 2026, JPY weakness contributed to a 2.1% revenue decline even as DPU grew. Investors should monitor the JPY/SGD exchange rate.
2. Premium Valuation Risk
PLife REIT trades at approximately 58% premium to NAV — a significant premium. If market sentiment shifts or interest rates rise sharply, the share price could re-rate downward toward NAV, resulting in capital losses even if DPU remains stable.
3. Japan Tenant Default Risk
One Japan nursing home tenant defaulted, highlighting operational risk in the Japan portfolio. While security deposits absorbed most of the impact, investors should monitor the pace of re-leasing and any further tenant stress.
4. Concentration in Singapore Hospitals
While the Singapore master-lease is stable, it represents over 67% of income and is with a single tenant group (IHH Healthcare via Parkway Pantai). Any material change to this relationship would significantly affect DPU.
5. Refinancing Risk (October 2026)
PLife REIT has major debt refinancing due in October 2026. It successfully extended its weighted average debt maturity to 3.2 years, but investors should watch for any refinancing news as it approaches.
How to Buy ParkwayLife REIT in Singapore
Singapore investors can buy PLife REIT (SGX: C2PU) through any SGX-connected brokerage. You can also use CPF OA funds to invest in PLife REIT under the CPF Investment Scheme (CPFIS) — see our CPFIS Calculator and CPF Investment Strategy guide for details.
Popular platforms for buying Singapore REITs include:
- Endowus — invest CPF and SRS funds into REIT-focused portfolios. Use our Endowus referral code for a fee rebate.
- Syfe — REIT+ and income portfolios with automatic rebalancing. Use our Syfe referral code for cashback.
- FSMOne — cost-effective brokerage for direct SGX stock purchases. See our FSMOne referral code.
If you plan to invest regularly in PLife REIT, consider using our DCA Investment Calculator to model the long-term impact of dollar-cost averaging into this REIT.
This article is for informational purposes only and does not constitute financial advice. Always do your own research and consult a licensed financial advisor before investing.